Loading...
107例KRAS突变阳性非小细胞肺癌患者临床分析
BACKGROUND AND OBJECTIVE: Kirsten rat sarcoma viral oncogene (KRAS) mutation is one of the major driver genes of non-small cell lung cancer (NSCLC). KRAS is a resistant predictor of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), which raises controversy because of its role...
Saved in:
| Published in: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
中国肺癌杂志编辑部
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5973060/ https://ncbi.nlm.nih.gov/pubmed/27215453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2016.05.02 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|